thiazoles has been researched along with Leukemia, Lymphocytic, Chronic, T Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adnan-Awad, S; Aittokallio, T; Anders, S; Andersson, EI; Bellanger, D; Brümmendorf, TH; Crispatzu, G; Cuesta-Mateos, C; Ding, W; Dufva, O; Eldfors, S; Ellonen, P; Faber, E; He, L; Herling, M; Huber, W; Kallioniemi, O; Khan, S; Koschmieder, S; Kytölä, S; Lagström, S; Lauhio, A; Mpindi, JP; Mustjoki, S; Oleś, M; Pemovska, T; Pietarinen, P; Pützer, S; Savolainen, ER; Schrader, A; Sellner, L; Siitonen, T; Stern, MH; Tang, J; Tomska, K; Wennerberg, K; Yadav, B; Zenz, T; Zhang, H | 1 |
1 other study(ies) available for thiazoles and Leukemia, Lymphocytic, Chronic, T Cell
| Article | Year |
|---|---|
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Cell Cycle; Cell Line, Tumor; Chromosome Aberrations; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Gene Expression; Gene Expression Profiling; High-Throughput Screening Assays; Humans; Janus Kinases; Leukemia, Prolymphocytic, T-Cell; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Oxazoles; Phenotype; Protein Kinase Inhibitors; STAT Transcription Factors; Thiazoles | 2018 |